Trials & Studies Topics
| 1 | Clinical Trials |
| 1.01 | ACUTE MANAGEMENT – NEITHER THROMBOLYSIS NOR THROMBECTOMY |
| 1.02 | ACUTE MANAGEMENT – THROMBOLYSIS OR THROMBECTOMY |
| 1.03 | PREVENTION |
| 1.04 | REHABILITATION & RECOVERY |
| 2 | Placeholder Late Breaking Clinical Trials (Results available at the conference) |
| 2.01 | PLACEHOLDER – NEITHER THROMBOLYSIS NOR THROMBECTOMY |
| 2.02 | PLACEHOLDER – THROMBOLYSIS OR THROMBECTOMY |
| 2.03 | PLACEHOLDER – PREVENTION |
| 2.04 | PLACEHOLDER – REHABILITATION & RECOVERY |
| 3 | Ongoing Trials (Poster only, results are NOT available at the conference) |
| 3.01 | ONGOING TRIALS |
| 4 | Studies – Excluding Trials |
| 4.01 | HYPERACUTE MANAGEMENT – EXCLUDING CLINICAL TRIAL RESULTS |
| 4.02 | THROMBOLYSIS – EXCLUDING CLINICAL TRIAL RESULTS |
| 4.03 | NEUROINTERVENTION – EXCLUDING CLINICAL TRIAL RESULTS |
| 4.04 | SECONDARY PREVENTION – EXCLUDING CLINICAL TRIAL RESULTS |
| 4.05 | REHABILITATION – EXCLUDING CLINICAL TRIAL RESULTS |
| 4.06 | EPIDEMIOLOGY & RISK FACTORS |
| 4.07 | IMAGING – HYPERACUTE |
| 4.08 | IMAGING – NON ACUTE INCLUDING NEUROSONOLOGY |
| 4.09 | DIAGNOSIS/INVESTIGATION OF STROKE ETIOLOGY |
| 4.10 | PROGNOSIS AND OUTCOME AFTER STROKE |
| 4.11 | STROKE COMPLICATIONS |
| 4.12 | CEREBROVASCULAR MANIFESTATIONS OF COVID-19 AND OTHER INFECTIONS |
| 4.13 | ATHEROSCLEROSIS & STROKE |
| 4.14 | RARE CAUSES, STROKE IN THE YOUNG (INCLUDING PAEDIATRIC STROKE) |
| 4.15 | CARDIOEMBOLISM & HEART-BRAIN INTERACTIONS |
| 4.16 | INTRACEREBRAL HAEMORRHAGE |
| 4.17 | SAH, ANEURYSMS AND VASCULAR MALFORMATIONS |
| 4.18 | COGNITION AND VASCULAR COGNITIVE IMPAIRMENT |
| 4.19 | SMALL VESSEL DISEASE |
| 4.20 | SEX, GENDER AND STROKE |
| 4.21 | PATHOPHYSIOLOGY OF STROKE / TRANSLATIONAL MEDICINE |
| 4.22 | GENETICS, ‘OMICS AND BIOMARKERS |
| 4.23 | CLINICAL PRACTICE, MANAGEMENT AND CARE |
| 4.24 | SERVICE ORGANISATION/QUALITY IMPROVEMENT AND PATIENT CENTERED OUTCOMES |
| 4.25 | BRAIN REORGANISATION AND RECOVERY |
| 4.26 | TECHNOLOGY INNOVATIONS: ROBOTS, VIRTUAL REALITY, ARTIFICIAL INTELLIGENCE AND MORE |
| 4.27 | CASE REPORTS |
| 4.28 | YOUNG STROKE PHYSICIANS AND RESEARCHERS: RESEARCH DESIGN WORKSHOP FOR STUDIES IN DEVELOPMENT * |
*This is a focused workshop directed to young investigators.
The main aim is to support young stroke researchers in promoting their research project under construction to the wider stroke community and to have their proposed study design reviewed in an open forum and by an expert mentor in the field. We hope that this will help young researchers to refine their study design and to promote collaboration with other groups and centres.
As in previous years, young investigators (<35 years) are invited to submit an abstract for the workshop describing a planned research study, an ongoing project still under development or interim results from an ongoing project.
The abstracts should be submitted to a special category (4.28: “YSPR design workshop for studies in development”).
The successful applicants will give an oral presentation, followed by constructive assessment of the study’s design and advice on its future development by a senior, internationally-renowned invited investigator. In addition to providing expert guidance on the development of the study, the workshop will be an opportunity for the young researchers to promote their work to the wider community and establish collaborations.
The presenters of the two top scoring abstracts will receive a place at the ESO Summer School or the ESO Edinburgh Stroke Winter School in 2023.
All presenters will be interviewed by other Young Stroke Physicians and Researchers and the interviews will be featured on the ESO blog (https://eso-stroke.org/news/).